Mechanisms and treatment of opioid‐induced pruritus: Peripheral and central pathways

Abstract Background and Objective Pruritus (also known as itch) is defined as an unpleasant and irritating sensation of the skin that provokes an urge to scratch or rub. It is well known that opioid administration can cause pruritus, which is paradoxical as itch and pain share overlapping sensory pathways. Because opioids inhibit pain but can cause itching. Significant progress has been made to improve our understanding of the fundamental neurobiology of itch; however, much remains unknown about the mechanisms of opioid‐induced pruritus. The prevention and treatment of opioid‐induced pruritus remains a challenge in the field of pain management. The objective of this narrative review is to present and discuss the current body of literature and summarize the current understanding of the mechanisms underlying opioid‐induced pruritus, and its relationship to analgesia, and possible treatment options. Results The incidence of opioid‐induced pruritus differs with different opioids and routes of administration, and the various mechanisms can be broadly divided into peripheral and central. Especially central mechanisms are intricate, even at the level of the spinal dorsal horn. There is evidence that opioid receptor antagonists and mixed agonist and antagonists, especially μ‐opioid antagonists and κ‐opioid agonists, are effective in relieving opioid‐induced pruritus. Various treatments have been used for opioid‐induced pruritus; however, most of them are controversial and have conflicting results. Conclusion The use of a multimodal analgesic treatment regimen combined with a mixed antagonist and κ agonists, especially μ‐opioid antagonists, and κ‐opioid agonists, seems to be the current best treatment modality for the management of opioid‐induced pruritus and pain. Significance Opioids remain the gold standard for the treatment of moderate to severe acute pain as well as cancer pain. It is well known that opioid‐induced pruritus often does not respond to regular antipruritic treatment, thereby posing a challenge to clinicians in the field of pain management. We believe that our review makes a significant contribution to the literature, as studies on the mechanisms of opioid‐induced pruritus and effective management strategies are crucial for the management of these patients.